Obesity Strategic Roundup | Jul 28 – Aug 31 , 2026
Obesity Strategic Roundup exploring Developments and Competitive Shifts…
Vida Health and Instacart Health Partner on Fresh Funds | Lucid Diligence Brief
Vida Health’s Instacart Health partnership tests whether grocery stipends can…
Public Health Today—April 24, 2026
This weekly Public Health update highlights key developments across policy,…
Obesity Today—April 7, 2026
This week’s Obesity update highlights regulatory progress, advancing late-stage…
Lucid Diligence Brief: Ambrosia Biosciences $100M Series B for oral GLP-1 asset
Lucid Diligence Brief: Ambrosia Biosciences $100M Series B for oral GLP-1……
Lucid Diligence Brief: Samsung Bioepis and G2GBIO long-acting semaglutide collaboration
Lucid Diligence Brief: Samsung Bioepis and G2GBIO long-acting semaglutide…
Lucid Diligence Brief: Hims & Hers to acquire Eucalyptus
Lucid Diligence Brief: Hims & Hers to acquire Eucalyptus Professional…
Lucid Diligence Brief: AstraZeneca and CSPC obesity and T2D collaboration
Lucid Diligence Brief: AstraZeneca and CSPC obesity and T2D collaboration…
Lucid Diligence Brief: CORXEL $287m Series D1 for oral GLP-1 development
Lucid Diligence Brief: CORXEL $287m Series D1 for oral GLP-1 development…
Obesity Video Recap—January 20, 2026
This biweekly Obesity video recap covers a mix of late-stage regulatory…
AI in Healthcare and Digital Health Video Recap —January 12, 2026
Here’s your AI in Healthcare and Digital Health video brief covering recent…
Lucid Diligence Brief: Alveus Therapeutics $159.8 million Series A
Lucid Diligence Brief: Alveus Therapeutics $159.8 million Series A Professional…